// insider-profile

WEITZMAN DEBORAH

OfficerTitle: CEO, Pharmaceutical SegmentView on SEC.gov ↗

// activity-summary

No insider transactions in the last 30 days.

// track-record

$0
Total purchased
$7.1M
Total sold
2
0B · 2S transactions
Net seller
Overall direction

Most active in

Filing history: Nov 2023Dec 2025Based on last 18 filings

Transaction History

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Dec 1, 2025WEITZMAN DEBORAHCAHTax Withholding551$212.26$117K
Aug 20, 2025WEITZMAN DEBORAHCAHSale21,367$150.53$3.22M
Aug 15, 2025WEITZMAN DEBORAHCAHAward10,694$0.00$0K
Aug 15, 2025WEITZMAN DEBORAHCAHTax Withholding24,128$150.22$3.62M
Aug 12, 2025WEITZMAN DEBORAHCAHAward39,100$0.00$0K

13 more transactions hidden

Free account · No credit card required

Building something? Get API access →